CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
On the same day, RBC Capital maintained its Outperform rating and $93 price target on CVS Health Corporation (NYSE:CVS) ...
This was the stock's second consecutive day of losses.
Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price ...
CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO ...
BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...
Zacks Investment Research on MSN
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
The outlook suggests Rhode Island-based CVS expects to manage a volatile environment that has posed challenges for all three ...
On November 13, Wells Fargo analyst Stephen Baxter lowered the firm’s price target on CVS Health Corporation (NYSE:CVS) ...
At Investor Day, CVS Health will update its 2025 full-year financial guidance, provide 2026 full-year financial guidance and introduce its expectations for a mid-teens Adjusted EPS compound annual ...
Shares of CVS Health Corp. CVS shed 1.57% to $79.10 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.53% to 6,812.63 and Dow ...
CVS Health’s Aetna health insurance unit said it will “integrate pharmacy prescriptions and medical procedures into a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback